Thu.Jun 13, 2024

article thumbnail

Type 1 Diabetes in Older People Has Nearly Tripled Globally Since the '90s

Med Page Today

(MedPage Today) -- Global prevalence of older people living with type 1 diabetes mellitus jumped 180% in the past 30 years, a population-based study found. This represents an increase from 1.3 million people worldwide in 1990 to 3.7 million in.

Diabetes 134
article thumbnail

Selected startups will advance technology-driven improvements in heart and brain health

American Heart News - Heart News

DALLAS, June 13, 2024 — The American Heart Association, through its Center for Health Technology and Innovation (the Center), has selected five companies to participate in the American Heart Association Heart and Brain Health Accelerator. The AHA.

article thumbnail

Health, Economic Burden of Comorbid Gout, CKD Projected to Increase Through 2035

HCPLive

Findings highlight an urgent need for improved gout management strategies to reduce costs, improve quality of life, and reduce gout symptoms in patients with comorbid gout and CKD.

article thumbnail

Xeltis Receives IDE Approval from FDA for Initiation of US Pivotal Trial for aXess, its Restorative Vascular Access Conduit

DAIC

Xeltis synthetic restorative pulmonary heart valve evolves into a fully functioning, natural heart valve through colonization by the patient’s own tissue. (Photo: Business Wire) milla1cf Thu, 06/13/2024 - 20:36 June 13, 2024 — Xeltis , a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces that it has gained approval from the US Food and Drug Administration ( FDA ) for an Investigational Device Exemption (IDE) submission to b

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Lp(a), Oxidized Phospholipids Can Predict Progression of Heart Failure, Study Finds

HCPLive

New research reveals that elevated lipoprotein(a) and oxidized phospholipids are independent risk factors for early-stage heart failure progression.

article thumbnail

El Camino Health Cardiologist Earns International Award for Achievements in Advancing Cardiovascular Field

DAIC

Image courtesy of El Camino Health milla1cf Thu, 06/13/2024 - 20:33 June 13, 2024 — Frederick St. Goar, MD, medical director at the Norma Melchor Heart & Vascular Institute , was distinguished with the Andreas Grüntzig Ethica Award , the highest global honor in interventional cardiology. Dr. St. Goar received the recognition during a special ceremony in Paris, France, along with esteemed cardiothoracic surgeon, Professor Ottavio Alfieri of San Raffaele Hospital in Milan, Italy.

More Trending

article thumbnail

A Message from Raja-Elie Abdulnour, MD, NEJM Journal Watch Editor-in-Chief

NEJM Journal Watch - Cardiology

Today's medical professionals need relevant, trusted, and timely medical information more than ever.

75
article thumbnail

Mental stress linked to increased heart risks in heart disease patients

Medical Xpress - Cardiology

Imagine walking through a park and suddenly spotting a bear. Normally your heart starts beating faster and your blood vessels constrict. That's the sympathetic nervous system preparing your body for a "flight or fight" response. Then, once you reach safety, your parasympathetic nervous system helps calm you down. Eventually, your blood pressure and heart rate return to normal.

article thumbnail

Predictors and 5-Year Outcomes of Pacemaker After TAVR

American College of Cardiology

What are the rates of a permanent pacemaker (PPM) implantation, the predictors of needing a PPM, and long-term clinical outcomes of the third-generation balloon-expandable SAPIEN 3 (S3) transcatheter heart valve (THV)?

article thumbnail

Reteplase versus Alteplase for Acute Ischemic Stroke

The New England Journal of Medicine

In this trial from China involving 1412 patients with acute ischemic stroke presenting within 4.5 hours, the percentage who had an excellent functional outcome at 90 days was 79.5% with reteplase and 70.4% with alteplase.

Stroke 68
article thumbnail

Nitroglycerin to Ameliorate Coronary Artery Spasm During AF Ablation

American College of Cardiology

What is the potential of focal pulsed field ablation (PFA) to provoke coronary spasm during cavotricuspid isthmus ablation, and does nitroglycerin use mitigate the risk of vasospasm in this setting?

article thumbnail

Potential JAK Inhibitor Combination Regimens in Dermatology

HCPLive

Matthew Zirwas, MD, discusses the prospect of pairing JAK inhibitors like ruxolitinib cream with other disease-targeting options for conditions including vitiligo and alopecia areata.

64
article thumbnail

Transcatheter Heart Valve Explant for Infective Endocarditis

American College of Cardiology

What are the outcomes of patients undergoing transcatheter heart valve (THV) explant in the setting of THV-associated infective endocarditis (IE)?

article thumbnail

Upadacitinib Led to Sustained, 140-Week Improvements for Atopic Dermatitis Patients

HCPLive

These data, presented at RAD 2024, highlight the potential benefits of upadacitinib for adults and adolescents observed in the Measure Up 1 and Measure Up 2 studies.

64
article thumbnail

Emerging Cardiovascular Diagnostics in Cardio-Rheumatology: Exploring FAPI PET-CT

American College of Cardiology

Immune-mediated systemic inflammatory disorders (IMIDs) are associated with an increased risk of cardiovascular disease (CVD), ranging from atherosclerosis to myocarditis and heart failure.

article thumbnail

Certolizumab Pegol Offers Consistent Benefit, Regardless of Rheumatoid Factor Levels

HCPLive

An analysis of the REALISTIC trial from EULAR 2024 details the effects of certolizumab pegol in rheumatoid arthritis based on rheumatoid factor levels and prior TNF inhibitor use.

59
article thumbnail

Unlocking Excellence in Healthcare: The Power of Centers of Excellence

ADN Center of Excellence

In the ever-evolving landscape of healthcare, the pursuit of excellence is an unwavering commitment. As medical professionals, strive to provide the highest quality of care, grounded in the latest advancements and best practices. This relentless quest for excellence has given rise to a pioneering concept: Centers of Excellence (CoEs) in healthcare. A Center of Excellence is a collaborative ecosystem that brings together renowned institutions, experienced professionals, and cutting-edge resources

article thumbnail

What Makes JAK Inhibitors Safe in Dermatology

HCPLive

Matthew Zirwas, MD, reviews the clinical discrepancies of certain JAK-targeting therapies and their role in dermatology patient outcomes.

article thumbnail

Efficacy of autologous blood patch injection for pneumothorax rate after CT-guided percutaneous transthoracic lung biopsy: a systematic review and meta-analysis

Journal of Cardiothoracic Surgery

Pneumothorax is the most frequent complication after CT-guided percutaneous transthoracic lung biopsy (CT-PTLB). Many studies reported that injection of autologous blood patch (ABP) during biopsy needle withdr.

52
article thumbnail

Dupilumab Versus Lebrikizumab with Topical Corticosteroids: Efficacy in Atopic Dermatitis

HCPLive

These data highlighted which drug, in combination with topical corticosteroids, produced the best efficacy results for those with atopic dermatitis.

59
article thumbnail

Unlocking Excellence in Healthcare: The Power of Centers of Excellence

ADN Center of Excellence

In the ever-evolving landscape of healthcare, the pursuit of excellence is an unwavering commitment. As medical professionals, strive to provide the highest quality of care, grounded in the latest advancements and best practices. This relentless quest for excellence has given rise to a pioneering concept: Centers of Excellence (CoEs) in healthcare. A Center of Excellence is a collaborative ecosystem that brings together renowned institutions, experienced professionals, and cutting-edge resources

article thumbnail

Hydroxyurea Therapy May Affect Fertility in Sickle Cell Disease

HCPLive

Hydroxyurea treatment may impact seminal fluid levels and ovarian reserves in male and female patients with sickle cell disease.

article thumbnail

Visura Technologies to Feature TEECAD mini for Use with Smaller Transesophageal Echocardiography (TEE) Probes During ASE 2024

DAIC

Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR.

article thumbnail

FDA Approval of Single-Dose Tralokinumab Autoinjector for Adults with Atopic Dermatitis

HCPLive

This approval by FDA officials allows patients an alternative option to pre-filled syringe, which had been the only choice for those with eczema prescribed tralokinumab.

59
article thumbnail

The Oasis: Q+A with Sam Bish

Conquering CHD

Sam is a former USMC mortarman and Computer Engineer now stay-at-home dad and caregiver to Cillian. He is the Co-Founder to Heart Warrior Ministries and facilitator to the Oasis, an online gaming group for dads with children who have Congenital Heat Disease. His vision to begin the Oasis began when he was inpatient for a year and wanting to connect with other dads for support and advice who shared the same passion.

article thumbnail

Therapies in Development for Hidradenitis Suppurativa

HCPLive

Jennifer L. Hsiao, MD, reviews the rapidly growing inventory of investigational drugs for HS.

59
article thumbnail

Blood vessels in a dish: the evolution, challenges, and potential of vascularized tissues and organoids

Frontiers in Cardiovascular Medicine

Vascular pathologies are prevalent in a broad spectrum of diseases, necessitating a deeper understanding of vascular biology, particularly in overcoming the oxygen and nutrient diffusion limit in tissue constructs. The evolution of vascularized tissues signifies a convergence of multiple scientific disciplines, encompassing the differentiation of human pluripotent stem cells (hPSCs) into vascular cells, the development of advanced three-dimensional (3D) bioprinting techniques, and the refinement

article thumbnail

Bimekizumab Response is Sustained Over 4 Years in Plaque Psoriasis

HCPLive

Responses were highly durable throughout 4 years of bimekizumab treatment.

Plaque 59
article thumbnail

FDA Update: Multi-Agency Task Force to Combat Illegal E-Cigarettes Announced

American College of Cardiology

The U.S. Food and Drug Administration (FDA) and U.S. Department of Justice announced on June 10 the creation of a multi-agency task force to curb the distribution and sale of illegal e-cigarettes.

Article 49
article thumbnail

Low-Pressure Hyperbaric Oxygen Therapy May Aid Pain Management in Women with Fibromyalgia

HCPLive

Findings highlight significant improvements in psychological constructs related to pain and quality of life following an 8-week intervention with hyperbaric oxygen therapy.

article thumbnail

Anomalous left main coronary artery originating from right coronary artery

Coronary Artery Disease Journal

No abstract available

40
article thumbnail

Biosimilar Introduction Reduces Biologic Prices in the US and Globally

HCPLive

After a biosimilar introduction, the prices of the biologic products—namely, trastuzumab, infliximab, bevacizumab, adalimumab, filgrastim, and pegfilgrastim—were significantly reduced.

59
article thumbnail

Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-blinded CRUSTY trial

HeartRhythm

Optimizing the AV pacing interval is critical for improving the response to cardiac resynchronization therapy (CRT),1,2 The SyncAV algorithm (Abbott Inc., Sylmar, CA) is a dynamic automatic algorithm designed to provide triple fusion between the left ventricle, right ventricle, and intrinsic conduction. Observational studies have shown an association with an increase in acute mechanical and hemodynamic response and an improvement in clinical response.35 However, no data from randomized clinical

40
article thumbnail

RA Linked to Increased Frailty Risk, Mediated by Inflammatory Cytokines

HCPLive

A new study found an indirect effect of RA on frailty index through inflammatory cytokines.

59
article thumbnail

Percutaneous intervention for beating coronary aneurysm in the septal branch

Coronary Artery Disease Journal

No abstract available

article thumbnail

Adults with Sickle Cell Report Poor Health-Related Quality of Life Scores

HCPLive

Based on the 36-item Short Form Survey questionnaire, adults with SCD in France report low physical and mental health summary scores.